Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 54
Filter
1.
Bioinformatics ; 35(5): 856-864, 2019 03 01.
Article in English | MEDLINE | ID: mdl-30137210

ABSTRACT

MOTIVATION: A major component in increasing our understanding of the biology of an organism is the mapping of its genotypic potential into its phenotypic expression profiles. This mapping is executed by the machinery of gene regulation, which is essentially studied by changes in growth conditions. Although many efforts have been made to systematize the annotation of experimental conditions in microbiology, the available annotations are not based on a consistent and controlled vocabulary, making difficult the identification of biologically meaningful comparisons of knowledge derived from different experiments or laboratories. RESULTS: We curated terms related to experimental conditions that affect gene expression in Escherichia coli K-12. Since this is the best-studied microorganism, the collected terms are the seed for the Microbial Conditions Ontology (MCO), a controlled and structured vocabulary that can be expanded to annotate microbial conditions in general. Moreover, we developed an annotation framework to describe experimental conditions, providing the foundation to identify regulatory networks that operate under particular conditions. AVAILABILITY AND IMPLEMENTATION: As far as we know, MCO is the first ontology for growth conditions of any bacterial organism, and it is available at http://regulondb.ccg.unam.mx and https://github.com/microbial-conditions-ontology. Furthermore, we will disseminate MCO throughout the Open Biological and Biomedical Ontology (OBO) Foundry in order to set a standard for the annotation of gene expression data. This will enable comparison of data from diverse data sources. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.


Subject(s)
Biological Ontologies , Computational Biology , Escherichia coli K12 , Information Storage and Retrieval , Software , Vocabulary , Vocabulary, Controlled
2.
J Thromb Haemost ; 8(7): 1555-66, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20345714

ABSTRACT

SUMMARY BACKGROUND: The involvement of plasminogen in liver repair has been reported, but its exact role in promoting this process is unknown. OBJECTIVE: To elucidate the underlying mechanism, we examined the dynamics of liver repair by using a reproducible liver injury model in plasminogen gene-deficient mice and their wild-type littermates. METHODS: Liver injury was induced by photochemical reaction and the subsequent responses were histologically analyzed. RESULTS: In wild-type animals, the area of the damage successively decreased, and the repair process was associated with macrophage accumulation at its border. Neutrophils were also attracted to the damaged region on day 1 and were evident only at its border by day 4, which spatially and temporally coincided with the expression of macrophage chemoattractant protein-1 (MCP-1). Neutrophil depletion suppressed recruitment of macrophages at the border between the damaged and the normal tissues. These changes were followed by activated hepatic stellate cell accumulation, collagen fiber deposition and angiogenesis at the boundaries of the injured zone. In contrast, in plasminogen gene-deficient mice, the decrease in the area of damage, macrophage accumulation, late-phase neutrophil recruitment, hepatic stellate cell accumulation, collagen fiber deposition and angiogenesis were all impaired. CONCLUSION: Our data suggest that accumulated neutrophils at the border of the damaged area may contribute to macrophage accumulation at granulation tissue via the production of MCP-1 after liver injury. The plasminogen system is critical for liver repair by facilitating macrophage accumulation and triggering a cascade of subsequent repair events.


Subject(s)
Chemical and Drug Induced Liver Injury , Granulation Tissue/growth & development , Liver Regeneration , Plasminogen/physiology , Animals , Cell Movement , Chemokine CCL2/biosynthesis , Hepatic Stellate Cells , Macrophages/physiology , Mice , Mice, Knockout , Neutrophils/physiology , Plasminogen/genetics
3.
Eur J Neurol ; 17(6): 823-9, 2010 Jun 01.
Article in English | MEDLINE | ID: mdl-20158508

ABSTRACT

BACKGROUND AND PURPOSE: The present study aims to clarify the clinical features of non-hypertensive cerebral amyloid angiopathy-related lobar intracerebral hemorrhage (CAA-L-ICH). METHODS: We investigated clinical, laboratory, and neuroimaging findings in 41 patients (30, women; 11, men) with pathologically supported CAA-L-ICH from 303 non-hypertensive Japanese patients aged >OR=55, identified via a nationwide survey as symptomatic CAA-L-ICH. RESULTS: The mean age of patients at onset of CAA-L-ICH was 73.2 +/- 7.4 years; the number of patients increased with age. The corrected female-to-male ratio for the population was 2.2, with significant female predominance. At onset, 7.3% of patients received anti-platelet therapy. In brain imaging studies, the actual frequency of CAA-L-ICHs was higher in the frontal and parietal lobes; however, after correcting for the estimated cortical volume, the parietal lobe was found to be the most frequently affected. CAA-L-ICH recurred in 31.7% of patients during the average 35.3-month follow-up period. The mean interval between intracerebral hemorrhages (ICHs) was 11.3 months. The case fatality rate was 12.2% at 1 month and 19.5% at 12 months after initial ICH. In 97.1% of patients, neurosurgical procedures were performed without uncontrollable intraoperative or post-operative hemorrhage. CONCLUSIONS: Our study revealed the clinical features of non-hypertensive CAA-L-ICH, including its parietal predilection, which will require further study with a larger number of patients with different ethnic backgrounds.


Subject(s)
Cerebral Amyloid Angiopathy/pathology , Cerebral Hemorrhage/pathology , Age Distribution , Age of Onset , Aged , Aged, 80 and over , Cerebral Amyloid Angiopathy/complications , Cerebral Hemorrhage/etiology , Female , Humans , Male , Middle Aged
4.
Insect Mol Biol ; 17(4): 341-50, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18651916

ABSTRACT

Gamma-hexachlorocyclohexane (gamma-HCH), fipronil and picrotoxinin are noncompetitive antagonists (NCAs) of L-glutamate-gated chloride channels (GluCls), yet their potencies are weaker than those on gamma-aminobutyric acid receptors (GABARs). The A302S mutation of Drosophila RDL (resistant to dieldrin) GABAR confers NCA resistance, and housefly GluCls (MdGluCls) possess S278 as the residue corresponding to the A302. Thus, the effects of S278A mutation on the NCA actions on MdGluCls were investigated. The S278A mutation resulted in enhanced blocking by NCAs of the MdGluCl response to 30 microM L-glutamate. However, such actions of gamma-HCH and picrotoxinin, but not of fipronil, on the S278A mutant were reduced with 200 microM L-glutamate. Further increases in the L-glutamate concentration led to potentiation by NCAs of the mutant response to L-glutamate.


Subject(s)
Chloride Channels/metabolism , Glutamic Acid/metabolism , Houseflies/metabolism , Insecticides/pharmacology , Ion Channel Gating/physiology , Serine/chemistry , Amino Acid Sequence , Amino Acid Substitution , Animals , Chloride Channels/genetics , Dose-Response Relationship, Drug , Hexachlorocyclohexane/chemistry , Hexachlorocyclohexane/pharmacology , Membrane Potentials/physiology , Molecular Structure , Picrotoxin/analogs & derivatives , Picrotoxin/chemistry , Picrotoxin/pharmacology , Pyrazoles/chemistry , Pyrazoles/pharmacology , Sesterterpenes , Sodium Chloride/pharmacology
5.
Neurology ; 64(4): 643-8, 2005 Feb 22.
Article in English | MEDLINE | ID: mdl-15728285

ABSTRACT

BACKGROUND: No method for the clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease (sCJD) has been established except for pathologic examination. OBJECTIVE: To identify a reliable marker for the clinical diagnosis of MM2-type sCJD. METHODS: CSF, EEG, and neuroimaging studies were performed in eight patients with MM2-type sCJD confirmed by neuropathologic, genetic, and western blot analyses. RESULTS: The eight cases were pathologically classified into the cortical (n = 2), thalamic (n = 5), and combined (corticothalamic) (n = 1) forms. The cortical form was characterized by late-onset, slowly progressive dementia, cortical hyperintensity signals on diffusion-weighted imaging (DWI) of brain, and elevated levels of CSF 14-3-3 protein. The thalamic form showed various neurologic manifestations including dementia, ataxia, and pyramidal and extrapyramidal signs with onset at various ages and relatively long disease duration. Characteristic EEG and MRI abnormalities were almost absent. However, all four patients examined with cerebral blood flow (CBF) study using SPECT showed reduction of the CBF in the thalamus as well as the cerebral cortex. The combined form had features of both the cortical and the thalamic forms, showing cortical hyperintensity signals on DWI and hypometabolism of the thalamus on [18F]2-fluoro-2-deoxy-d-glucose PET. CONCLUSION: For the clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease, cortical hyperintensity signals on diffusion-weighted MRI are useful for the cortical form and thalamic hypoperfusion or hypometabolism on cerebral blood flow SPECT or [18F]2-fluoro-2-deoxy-d-glucose PET for the thalamic form.


Subject(s)
Creutzfeldt-Jakob Syndrome/diagnosis , 14-3-3 Proteins/cerebrospinal fluid , Age of Onset , Aged , Alzheimer Disease/diagnosis , Biomarkers , Blotting, Western , Cerebral Cortex/diagnostic imaging , Cerebral Cortex/pathology , Cerebral Cortex/physiopathology , Cerebrospinal Fluid Proteins/analysis , Cerebrovascular Circulation , Creutzfeldt-Jakob Syndrome/cerebrospinal fluid , Creutzfeldt-Jakob Syndrome/classification , Creutzfeldt-Jakob Syndrome/epidemiology , Creutzfeldt-Jakob Syndrome/genetics , Creutzfeldt-Jakob Syndrome/physiopathology , Diagnosis, Differential , Diffusion Magnetic Resonance Imaging , Electroencephalography , Female , Fluorodeoxyglucose F18 , Humans , Male , Middle Aged , Phenotype , Positron-Emission Tomography , Prions/genetics , Supranuclear Palsy, Progressive/diagnosis , Thalamus/blood supply , Thalamus/diagnostic imaging , Thalamus/pathology , Tomography, Emission-Computed, Single-Photon
6.
J Neurol Neurosurg Psychiatry ; 76(3): 325-9, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15716520

ABSTRACT

OBJECTIVE: To investigate abnormal prion protein (PrP) deposition in the peripheral nervous system (PNS) in human prion diseases. METHODS: Eight patients with prion diseases were examined: three with sporadic Creutzfeldt-Jakob disease (sCJD), two with dural graft associated CJD (dCJD), one with Gerstmann-Straussler-Scheinker disease (GSS) with a PrP P102L mutation (GSS102), and two with a P105L mutation (GSS105). An atypical case of sCJD with PrP plaques in the brain presented clinically with peripheral neuropathy, and showed demyelination in 12% of the teased fibres of the sural nerve. The PNS was investigated by immunohistochemical and western blotting analyses of PrP. RESULTS: In immunohistochemical studies, granular PrP deposits were detected in some neurones of dorsal root ganglia and a few fibres of peripheral nerves and spinal posterior roots in one sCJD and two dCJD patients, but not in GSS102 or GSS105 patients. The atypical case of sCJD with peripheral neuropathy showed no obvious PrP deposition in the nerves. Western blotting analysis of the PNS from the dCJD patients revealed a small amount of protease K resistant PrP in the dorsal root ganglia and peripheral nerves. CONCLUSIONS: Abnormal PrP deposition occurs in the dorsal root ganglia and peripheral nerves in sCJD and dCJD. The PrP deposits in the PNS are not correlated with clinical manifestation of peripheral neuropathy in CJD.


Subject(s)
Creutzfeldt-Jakob Syndrome/physiopathology , Peripheral Nervous System Diseases/physiopathology , Peripheral Nervous System/pathology , Prions/analysis , Adult , Aged , Autopsy , Blotting, Western , Creutzfeldt-Jakob Syndrome/genetics , DNA Mutational Analysis , Dura Mater/transplantation , Female , Ganglia, Spinal/pathology , Humans , Immunohistochemistry , Male , Middle Aged , Prions/genetics
7.
Acta Physiol Scand ; 179(1): 49-59, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12940938

ABSTRACT

AIM: To observe hemichrome formation in human haemoglobin A under various buffer conditions. METHOD: Hemichrome formation of human oxyhaemoglobin A (HbO2) was studied spectrophotometrically in 0.1 m buffer at various temperatures and pH values. RESULTS: Following autoxidation in ferrous HbO2, it was evident that formation of hemichrome, which tends to precipitate, occurred at various stages during the course of the autoxidation reaction namely at initial, intermediate or final stages, depending on temperature and pH of the solution. By varying temperature of the solution from 35 to 55 degrees C and pH from 4.5 to 10.5, it is shown here that HbO2 exhibits high susceptibility for hemichrome formation and its occurrence is a function of pH, temperature and progress of autoxidation of HbO2. Unlike HbO2 and its separated haemoglobin chains, monomeric bovine heart myoglobin (MbO2) did not easily form hemichrome. CONCLUSION: These findings provide a clue on the crucial role of haemoglobin molecule for senescent cell recognition or homeostasis in the blood circulation.


Subject(s)
Hemeproteins/chemistry , Hemoglobin A/chemistry , Oxyhemoglobins/chemistry , Animals , Buffers , Cattle , Humans , Hydrogen-Ion Concentration , Myoglobin/chemistry , Oxidation-Reduction , Protein Denaturation , Spectrophotometry , Temperature
8.
Neurology ; 60(3): 514-7, 2003 Feb 11.
Article in English | MEDLINE | ID: mdl-12578942

ABSTRACT

The authors report a 75-year-old woman with atypical sporadic Creutzfeldt-Jakob disease (CJD) characterized by MM1-type prion protein (PrP) (methionine homozygosity at codon 129 in the PrP gene and type-1 protease-resistant PrP) and PrP plaques. This patient is the first case of sporadic CJD with plaque-forming MM1-type PrP, suggesting either a shared prion strain with the plaque-forming subset of dural graft-associated CJD or shared host genetic factors that are unrelated to the PrP genotype.


Subject(s)
Creutzfeldt-Jakob Syndrome/diagnosis , Plaque, Amyloid/pathology , Prions/analysis , Aged , Blotting, Western , Brain/pathology , Brain Chemistry , Cerebrospinal Fluid Proteins/analysis , Creutzfeldt-Jakob Syndrome/complications , Creutzfeldt-Jakob Syndrome/pathology , Electroencephalography , Female , Gliosis/etiology , Gliosis/pathology , Humans , Immunohistochemistry , Inappropriate ADH Syndrome/complications , Inappropriate ADH Syndrome/diagnosis , Magnetic Resonance Imaging , Prions/genetics
9.
Kansenshogaku Zasshi ; 75(5): 406-10, 2001 May.
Article in Japanese | MEDLINE | ID: mdl-11424490

ABSTRACT

We studied the serological cross-reactions among Bartonella henselae, Chlamydia pneumoniae and Coxiella burnetii by indirect fluorescence antibody (IFA) method, using sera from 8 patients with cat scratch disease (CSD), 13 patients with C. pneumoniae infection and 12 patients with acute Q fever. B. henselae IgG antibody was negative in 13 patients with C. pneumoniae infection, and was positive in 3 (titers being 1:64) of 12 patients with Q fever, whereas B. henselae IgM antibody was negative in all the patients with C. pneumoniae infection or Q fever. C. burnetii IgG antibody was removed by absorption of these 3 sera with C. burnetii antigens, whereas B. henselae IgG antibody did not change. C. pneumoniae IgG antibody was positive in 3 (titers being 1:125 in two, 1:32 in one) of 8 patients with CSD. Both C. pneumoniae and B. henselae IgG antibody titers were significantly reduced by absorption of these 3 sera with B. henselae antigens. C. burnetii IgG or IgM antibodies were negative in all patients with CSD. In conclusion, no serological cross-reaction between B. henselae and C. burnetii was observed. On the other hand. B. henselae IgG antibody cross-reacted to C. pneumoniae antigens, whereas C. pneumoniae IgG antibody did not cross-react to B. henselae antigens. Our findings suggest that determination of B. henselae IgG or IgM antibodies were not influenced by C. pneumoniae and C. burnetii antigens.


Subject(s)
Bartonella henselae/immunology , Chlamydophila pneumoniae/immunology , Coxiella burnetii/immunology , Fluorescent Antibody Technique, Indirect , Cat-Scratch Disease/immunology , Chlamydophila Infections/immunology , Cross Reactions , Humans , Q Fever/immunology
11.
Kansenshogaku Zasshi ; 75(2): 133-6, 2001 Feb.
Article in Japanese | MEDLINE | ID: mdl-11260879

ABSTRACT

We studied on the infection of domestic cat and dog fleas with Bartonella henselae by polymerase chain reaction (PCR). A total of 62 fleas (36 Ctenocephalidis felis from cats, 24 C. felis from dogs and 2 Ctenocephalidis canis from dogs), stored in 70% ethanol, were analyzed by PCR for B. henselae specific DNA. Of the 62 fleas, C. felis from cats and dogs were positive for B. henselae specific DNA in 12 of the 36 (33.3%) and in 5 of the 24 (20.8%), respectively, and C. canis from dogs was positive in 2 of the 2 (100%). Our results demonstrated that pet fleas were infected with B. henselae, and suggest that flea transmission of B. henselae between cats or dogs may occur, and direct transmission of B. henselae from pet fleas to human may cause cat scratch disease.


Subject(s)
Bartonella henselae/isolation & purification , Cat Diseases/parasitology , Cat-Scratch Disease/transmission , Cats/parasitology , Dog Diseases/parasitology , Dogs/parasitology , Ectoparasitic Infestations/veterinary , Siphonaptera/microbiology , Zoonoses/etiology , Animals , Humans
12.
Clin Diagn Lab Immunol ; 8(2): 454-9, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11238239

ABSTRACT

Although a serum thermolabile beta-2 macroglycoprotein (TMG) may play a role in host defense as a lectin, little is known of its related physiological functions, mainly due to a lack of appropriate methods for tracing the functions of TMG. We identified a polysaccharide from Aerococcus viridans, PSA, which reacts with TMG, and based on this finding, we developed an enzyme-linked immunosorbent assay to trace the functions of TMG. Using ethanol precipitation and DEAE-Sepharose and Sephacryl S-400 column chromatographies, we isolated PSA from cultured medium of A. viridans, and it exhibited specific binding against TMG in blood samples. In sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), the isolated PSA showed ladder bands that implied the existence of repeating units composed of D-glucose, N-acetyl-D-glucosamine, D-mannose, and D-xylose, as confirmed by gas chromatography-mass spectrometry. SDS-PAGE and immunochemical analysis, using rabbit anti-TMG antibody, showed that PSA specifically binds solely to intact serum TMG but not to TMG heated at 56 degrees C for 30 min, a condition under which antigenicity is lost. TMG in serum samples bound to PSA in a dose-dependent manner, and this binding was clearly suppressed by addition of PSA. These observations indicate that PSA is a useful adsorbent to TMG and can be used to develop appropriate methods for tracing the functions of TMG.


Subject(s)
Enzyme-Linked Immunosorbent Assay/methods , Glycoproteins/analysis , Polysaccharides, Bacterial/immunology , Streptococcaceae/immunology , Antibodies, Bacterial/immunology , Autoantibodies/blood , Autoantibodies/immunology , Glycoproteins/immunology , Glycoproteins/metabolism , Humans , Immunoblotting , Lectins , Lupus Erythematosus, Systemic/immunology , Polysaccharides, Bacterial/isolation & purification , Polysaccharides, Bacterial/metabolism , Precipitin Tests , Protein Binding/immunology
13.
AIDS Res Hum Retroviruses ; 17(2): 125-35, 2001 Jan 20.
Article in English | MEDLINE | ID: mdl-11177392

ABSTRACT

We previously reported that 71-kDa heat shock cognate protein (HSC70) was expressed on the cell surface of human T cell lymphotropic virus type 1 (HTLV-1)-susceptible cells and that HSC70, beta-actin, and a lipid-like component on the target cell membrane participated in syncytium formation by HTLV-1. We have now identified this lipid-like component to be palmitoyl (16:0)-oleoyl (18:1)-phosphatidylglycerol (POPG), using preparative thin-layer chromatographic fractionation and tandem mass spectrometric analysis. In the syncytium formation assay, exogenously added PG inhibited cell-to-cell transmission of HTLV-1 in a dose-dependent manner. Other phospholipids showed less (PE) or no effect (PC, PS, PI, PA, lysoPC, lysoPE, and CL). Binding experiments showed that PG interacted with three synthetic peptides, gp46--111, gp46--197, and gp21--400, which correspond to regions Lys111--Asp138 and Asp197--Leu216 on the gp46 surface glycoprotein, and to region Cys400--Leu429 on the gp21 transmembrane glycoprotein, respectively, as well as with intact gp46 and gp21 proteins of HTLV-1. On the other hand, HSC70 and beta-actin interacted with gp46--197 and gp46, not with gp46--111. However, the eluate from an affinity column coupled with gp46--111 contained not only PG but also HSC70 and beta-actin, despite the lack of direct interaction between gp46--111 and these proteins. In the in vitro binding assay, HSC70 showed interaction with both PG and beta-actin, while there was no evidence of any interaction between PG and beta-actin. These results suggest that HSC70 molecules on target cell surface interact with both PG in lipid bilayers and intracellular beta-actin and that these three cellular components form a receptor complex that plays a critical role in syncytium formation induced by HTLV-1-bearing cells.


Subject(s)
Giant Cells/physiology , Human T-lymphotropic virus 1/pathogenicity , Phosphatidylglycerols/physiology , T-Lymphocytes/pathology , T-Lymphocytes/virology , Actins/metabolism , Cell Line , Chromatography, Thin Layer , Dose-Response Relationship, Drug , Gene Products, env/metabolism , HSC70 Heat-Shock Proteins , HSP70 Heat-Shock Proteins/metabolism , Human T-lymphotropic virus 1/drug effects , Human T-lymphotropic virus 1/metabolism , Humans , Mass Spectrometry , Phosphatidylglycerols/pharmacology , Protein Binding , Receptors, Virus/metabolism , Retroviridae Proteins, Oncogenic/metabolism , T-Lymphocytes/drug effects , env Gene Products, Human Immunodeficiency Virus
14.
Kekkaku ; 76(12): 729-39, 2001 Dec.
Article in Japanese | MEDLINE | ID: mdl-11806129

ABSTRACT

The detection rate of mycobacteria from patients' specimens and the time required to get positive culture were compared among newly developed MYCOACID SYSTEM, MGIT, Ogawa K medium and 2% Ogawa medium (S). A total of 249 sputum samples taken from patients were used as the study subjects and 124 kinds of mycobacteria were isolated. For 135 cases clinically diagnosed as pulmonary tuberculosis, the detection rate was 44.4% for MYCOACID, 47.4% for MGIT and 38.5% for Ogawa K medium, showing that there are no significant differences in the detection rate between MYCOACID and MGIT, and MYCOACID and Ogawa K medium but the differences was significant between MGIT and Ogawa K medium (p = 0.02). The mean days needed for detection of Mycobacterium tuberculosis complex was 12.3 days for MYCOACID, 13.4 days for MGIT, and 26.8 days for Ogawa K medium, indicating significant differences in the time to get positive culture between Ogawa K medium and either of both liquid media (p < 0.001). Furthermore, 2% Ogawa medium (S) was used only for the detection of mycobacteria among previously untreated tuberculosis and there were no significant differences in the detection rate between 2% Ogawa medium (S) and either of both liquid media. The time to get positive culture for 2% Ogawa medium (S) was 18.2 days, which was longer than that for either of liquid media, MYCOACID and MGIT, but it was significantly shorter (7.9 days) than that for Ogawa K medium (p = 0.003). These results demonstrate that the liquid culture systems both MYCOACID and MGIT were very useful for the detection of mycobacteria compared with Ogawa K medium.


Subject(s)
Culture Media , Mycobacterium/isolation & purification , Bacteriological Techniques , Humans , Sputum/microbiology , Time Factors
15.
Nihon Rinsho ; 59 Suppl 8: 406-13, 2001 Dec.
Article in Japanese | MEDLINE | ID: mdl-11808255

Subject(s)
Epilepsy , Adolescent , Adult , Child , Female , Humans , Male
16.
Gan To Kagaku Ryoho ; 27 Suppl 3: 649-52, 2000 Dec.
Article in Japanese | MEDLINE | ID: mdl-11190312

ABSTRACT

The subjects for this study were patients in remission discharged from the Palliative Care Unit (PCU) between January 1 and December 31, 1999. There were 72 patients, which represents 22% of all discharged patients during the same period. The objective of this study was to clarify nursing intervention in the transition from admission to the PCU to the transfer to home care and primary factors in this process. The study of medical records and inquiries made of primary nurses served as methods for this. Unless patients or their families have the desire to shift to home care, the transfer is difficult. However, as a result of information provisioning and coordination through nursing intervention concerning the home care support system, the transfer to home care was possible for 22% of all discharged patients. Primary factors in the transfer to home care are that: 1. patients have the desire to shift to home care; 2. patients' families accept home care; 3. symptoms are controlled to the level sought by the patients; 4. patient's clinical process can be observed continuously by the PCU outpatient clinic; and 5. there are adequate preparations to receive patients in an emergency.


Subject(s)
Home Care Services, Hospital-Based , Palliative Care , Caregivers , Humans , Neoplasms/therapy , Patient Compliance , Patient Discharge
18.
Plant Mol Biol ; 40(2): 307-21, 1999 May.
Article in English | MEDLINE | ID: mdl-10412909

ABSTRACT

Prenyltransferases (prenyl diphosphate synthases), which are a broad group of enzymes that catalyze the consecutive condensation of homoallylic diphosphate of isopentenyl diphosphates (IPP, C5) with allylic diphosphates to synthesize prenyl diphosphates of various chain lengths, have highly conserved regions in their amino acid sequences. Based on the above information, three prenyltransferase homologue genes were cloned from a thermophilic cyanobacterium, Synechococcus elongatus. Through analyses of the reaction products of the enzymes encoded by these genes, it was revealed that one encodes a thermolabile geranylgeranyl (C20) diphosphate synthase, another encodes a farnesyl (C15) diphosphate synthase whose optimal reaction temperature is 60 degrees C, and the third one encodes a prenyltransferase whose optimal reaction temperature is 75 degrees C. The last enzyme could catalyze the synthesis of five prenyl diphosphates of farnesyl, geranylgeranyl, geranylfarnesyl (C25), hexaprenyl (C30), and heptaprenyl (C35) diphosphates from dimethylallyl (C5) diphosphate, geranyl (C10) diphosphate, or farnesyl diphosphate as the allylic substrates. The product specificity of this novel kind of enzyme varied according to the ratio of the allylic and homoallylic substrates. The situations of these three S. elongatus enzymes in a phylogenetic tree of prenyltransferases are discussed in comparison with a mesophilic cyanobacterium of Synechocystis PCC6803, whose complete genome has been reported by Kaneko et al. (1996).


Subject(s)
Cyanobacteria/genetics , Dimethylallyltranstransferase/genetics , Multigene Family , Amino Acid Sequence , Cloning, Molecular , Cyanobacteria/enzymology , DNA/chemistry , DNA/genetics , Dimethylallyltranstransferase/metabolism , Evolution, Molecular , Molecular Sequence Data , Open Reading Frames , Phylogeny , Sequence Alignment , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Temperature
19.
Biosci Biotechnol Biochem ; 63(2): 261-70, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10192906

ABSTRACT

A geranylgeranyl diphosphate (GGPP) synthase gene of an extremely thermophilic bacterium, Thermus thermophilus, was cloned and sequenced. T. thermophilus GGPP synthase, overexpressed in Escherichia coli cells as a glutathione S-transferase fusion protein, was purified and characterized. The fusion protein, retaining thermostability, formed a homodimer, and showed higher specific activity than did a partially purified thermostable enzyme previously reported. Optimal reaction conditions and kinetic parameters were also examined. The deduced amino acid sequence indicated that T. thermophilus GGPP synthase was excluded from the group of bacterial type GGPP synthases and lacked the insertion amino acid residues in the first aspartate-rich motif as do archaeal and eukaryotic short-chain prenyltransferases.


Subject(s)
Alkyl and Aryl Transferases/genetics , Gene Expression Regulation, Bacterial , Thermus thermophilus/genetics , Alkyl and Aryl Transferases/chemistry , Amino Acid Sequence , Blotting, Southern , Chromatography, Affinity , Chromatography, Thin Layer , Cloning, Molecular , DNA Probes/chemistry , DNA, Bacterial/chemistry , Electrophoresis, Polyacrylamide Gel , Farnesyltranstransferase , Glutathione Transferase/chemistry , Kinetics , Molecular Sequence Data , Phylogeny , Polymerase Chain Reaction , Recombinant Fusion Proteins/chemistry , Sequence Alignment , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Thermus thermophilus/enzymology
20.
Alzheimer Dis Assoc Disord ; 13(1): 20-5, 1999 Jan.
Article in English | MEDLINE | ID: mdl-10192638

ABSTRACT

The purpose of the present study was to evaluate methanesulfonyl fluoride (MSF), a very long-acting CNS-selective acetylcholinesterase (AChE) inhibitor, as a palliative treatment for senile dementia of the Alzheimer type (SDAT). In experiment I, MSF (0.03-0.18 mg/kg) was administered orally to 10 normal volunteers to measure toxicity and establish dose/response function in erythrocyte AChE. MSF produced a dose-response function of %inhibition = (40)(Log10[MSF mg/kg] + 51.7) with no toxicity at these doses. Experiment II was a 16-week double-blind, placebo-controlled study of the safety and efficacy of MSF in doses of up to 0.18 mg/kg given three times per week in 5 men and 10 women (60-82 years), with Mini-Mental State Examination (MMSE) scores of 9-24, who had SDAT. MSF produced a mean of 89.5% inhibition of erythrocyte AChE in patients and improved cognitive performance as measured by the MMSE, Alzheimer Disease Assessment Scale-Cognitive Subscale (ADAS-COG), Global Deterioration Scale, and the Clinical Interview Based Impression of Change (CIBIC). Most of the improvement on the ADAS-COG was maintained 8 weeks after ending MSF. No patients left the study because of drug-related adverse events and there were no toxic effects. MSF may be a safe and effective palliative treatment for SDAT and further clinical trials in larger groups of patients are warranted.


Subject(s)
Alzheimer Disease/drug therapy , Cholinesterase Inhibitors/therapeutic use , Dementia/drug therapy , Sulfones/therapeutic use , Acetylcholinesterase/drug effects , Acetylcholinesterase/metabolism , Administration, Oral , Adult , Alzheimer Disease/pathology , Cholinesterase Inhibitors/administration & dosage , Cholinesterase Inhibitors/pharmacology , Cognition/drug effects , Dementia/pathology , Dose-Response Relationship, Drug , Double-Blind Method , Female , Humans , Male , Middle Aged , Palliative Care , Sulfones/administration & dosage , Sulfones/pharmacology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...